Protembis
Manufacturing · Germany · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Pauwelsstraße 17, Aachen, Nordrhein-West...Phone Number
+49 24199033622Website
www.protembis.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Protembis
Protembis, founded in 2013 and headquartered in Aachen, Germany, specializes in developing innovative technologies aimed at reducing the risk of significant brain lesions and stroke during cardiology procedures, particularly transcatheter aortic valve replacement (TAVR). Their flagship product, the ProtEmbo Cerebral Protection System, is designed to protect the brain from large clinically meaningful cerebral lesions during these procedures. The company targets patients undergoing TAVR and healthcare professionals involved in cardiology. Protembis is currently engaged in multiple clinical studies to validate the efficacy and safety of their technology.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Protembis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Protembis, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Protembis
Check out if Protembis is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Protembis recently announced quarterly report
Funding: Get notified immidiatlly once Protembis has new funding data
Check if Protembis has recently received funding, and reach out quickly before it becomes old news!
Click to see if Protembis had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Protembis launches new products
Recommended Actions
Find VP level buyers at Protembis
Find 2 more new buyers
Company Profile Activity
Activity Insights
Protembis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Protembis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Protembis.
Protembis financials insights
Gather financial insights about Protembis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$10M
2024
Series B
$33.6M
Protembis Tech Stack
A closer look at the technologies used by Protembis
See more technologies
Most Recent Scoops
Executive Move
Board of Directors
Funding
Funding
Executive Move
Board of Directors
Executive Move
Protembis News & Media
EIB invests €20M in Protembis, a German startup that develops brain protection device
German startup, Protembis, has secured a €20M venture-debt financing from the EIB to develop cerebral embolic protection system.German medtech Protembis raises €20M for brain protection during heart procedures.
German Medtech Protembis has raised €20 million in venture debt financing from The European Investment Bank (EIB) to develop a next-generation device for protecting the brains of patients who undergo...20 million Euros in venture debt: Taylor Wessing advises Protembis GmbH on financing by ...
Taylor Wessing advises Protembis GmbH on financing by the European Investment Bank ✅ Read now!Protembis Receives €20M in Venture Financing From EIB
Protembis, an Aachen, Germany-based medical-technology company, received €20m in venture-debt financing. The European Investment Bank (EIB) provided the financing. The company intends to use the proceeds to: Led by Co-Chief Executive Officers Karl von Mangoldt and Conrad Rasmus, Protembis is advancing a next-generation device for protecting the brains of patients who undergo certain heart treatments. […] The post Protembis Receives €20M in Venture Financing From EIB appeared first on FinSMEs.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Protembis
Sign Up For FreeTo access detailed company insights
Protembis, founded in 2013 and headquartered in Aachen, Germany, specializes in developing innovative technologies aimed at reducing the risk of significant brain lesions and stroke during cardiology procedures, particularly transcatheter aortic valve replacement (TAVR). Their flagship product, the ProtEmbo Cerebral Protection System, is designed t... Read More
